Longeveron (LGVN) Change in Acquisitions & Divestments (2021 - 2024)
Longeveron (LGVN) recorded quarterly Change in Acquisitions & Divestments of $2000.0 in Q3 2024, down 99.31% quarter-over-quarter from $289000.0 in Q2 2024, and down 99.95% on a YoY basis from $3.9 million in Q4 2023.
Longeveron (LGVN) Change in Acquisitions & Divestments (2021 - 2024) Analysis & Trends
Longeveron's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $2000.0 for Q3 2024.
- In Q3 2024, Change in Acquisitions & Divestments fell 99.95% year-over-year to $2000.0; the TTM figure through Dec 2024 stood at $352000.0 (down 96.04% YoY), while the FY2024 annual figure was $352000.0, down 96.04% from the prior year.
- Change in Acquisitions & Divestments was $2000.0 for Q3 2024 at Longeveron, down from $289000.0 in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $4.7 million in Q3 2021 to a low of $2000.0 in Q3 2024.
- Historically, Change in Acquisitions & Divestments has averaged $1.5 million across 4 years, with a median of $770000.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments soared 211.74% in 2022, then plunged 99.95% in 2024.
- A 4-year view of Change in Acquisitions & Divestments shows it stood at $247000.0 in 2021, then jumped by 211.74% to $770000.0 in 2022, then jumped by 136.75% to $1.8 million in 2023, then plunged by 99.89% to $2000.0 in 2024.
- The last three Change in Acquisitions & Divestments figures came in at $2000.0 (Q3 2024), $289000.0 (Q2 2024), and $61000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 1.82 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 3.94 Mn |
| Sep 30, 2023 | 3.94 Mn |
| Jun 30, 2023 | 2.66 Mn |
| Jun 30, 2023 | 2.66 Mn |
| Mar 31, 2023 | 461,000.00 |
| Mar 31, 2023 | 461,000.00 |
| Dec 31, 2022 | 770,000.00 |
| Dec 31, 2022 | 770,000.00 |
| Sep 30, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Dec 31, 2021 | 247,000.00 |
| Dec 31, 2021 | 247,000.00 |